Silence Therapeutics plc (SLN)
NASDAQ·Healthcare·Biotechnology
$11.57
-5.94%
Mkt Cap $292.38M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
Implied Upside
+392.7%
Consensus $57.00 vs current $11.57
NASDAQ·Healthcare·Biotechnology
$11.57
-5.94%
Mkt Cap $292.38M
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
+392.7%
Consensus $57.00 vs current $11.57